Source:http://linkedlifedata.com/resource/pubmed/id/18036826
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-1-28
|
pubmed:abstractText |
This study was aimed to develop a glycopeptide (GP) to be used as a carrier for anti-cancer drug delivery. GP was synthesized by conjugating glutamate peptide and chitosan using carbodiimide as a coupling agent. Elemental analysis and capillary electrophoresis confirmed the purity was >95%. GP was labeled with sodium pertechnetate (Na99m TcO4) for in vitro and in vivo studies. Rhenium-GP was synthesized to support the binding site of 99m Tc at the glutamate positions 3-5. In vitro cellular uptake of 99m Tc-GP was performed in breast cancer cells. Cytosol had 60% whereas nucleus had 40% uptake of 99m Tc-GP. When cancer cells were incubated with glutamate or aspartate, followed by 99m Tc-GP, there was decreased uptake in cells treated with glutamate but not aspartate. The findings indicated that cellular uptake of 99m Tc-GP was via glutamate transporters. In addition, 99m Tc-GP was able to measure uptake differences after cells treated with paclitaxel. Biodistribution and planar imaging were conducted in breast tumor-bearing rats. Biodistribution of 99m Tc-GP showed increased tumor-to-tissue ratios as a function of time. Planar images confirmed that 99m Tc-GP could assess tumor uptake changes after paclitaxel treatment. In vitro and in vivo studies indicated that GP could target tumor cells, thus, GP may be a useful carrier for anti-cancer drug delivery.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0969-8043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
320-31
|
pubmed:meshHeading |
pubmed-meshheading:18036826-Animals,
pubmed-meshheading:18036826-Area Under Curve,
pubmed-meshheading:18036826-Cell Line, Tumor,
pubmed-meshheading:18036826-Female,
pubmed-meshheading:18036826-Glycopeptides,
pubmed-meshheading:18036826-Isotope Labeling,
pubmed-meshheading:18036826-Mammary Neoplasms, Experimental,
pubmed-meshheading:18036826-Organotechnetium Compounds,
pubmed-meshheading:18036826-Radiopharmaceuticals,
pubmed-meshheading:18036826-Rats,
pubmed-meshheading:18036826-Rats, Inbred F344,
pubmed-meshheading:18036826-Scintillation Counting,
pubmed-meshheading:18036826-Tissue Distribution
|
pubmed:year |
2008
|
pubmed:articleTitle |
99m Tc-glycopeptide: synthesis, biodistribution and imaging in breast tumor-bearing rodents.
|
pubmed:affiliation |
Center for Innovation Development, Taiwan Hopax Chems Mfg. Co., Ltd., No. 28, Hua Dong Road, Daliao, Kaohsiung 83162, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|